October18 , 2026

    Pluss unveils Celsure® XL VIP Pallets

    Related

    VOC Port Records 263.24% Growth in Cement Cargo Handling in H1 FY 2026–27

    V.O. Chidambaranar Port Authority (VOC Port) has recorded an...

    Indian Exporters Prepare Shipments as India–New Zealand FTA Takes Effect on October 20

    Indian exporters are preparing consignments for shipment to New...

    Jindal Steel Commissions 12.5 MTPA Cargo Terminal at Paradip

    Jindal Steel has commissioned the first phase of a...

    Maersk Slashes Import Surcharges for New Delhi by 48.4%

    Global shipping major Maersk has cut import surcharges for...

    Share

    The temperature-controlled packaging solutions provider Pluss Advanced Technologies unveiled Celsure® XL VIP pallets.

    “Designed to meet the growing demands of the global pharmaceutical market, these VIP pallets offer unparalleled reliability, affordability, and sustainability,” reads the release.

    Crafted with precision using premium materials and incorporating the latest in vacuum-insulated panel (VIP) technology and phase change material (PCM), the pallets ensure temperature integrity during transit and storage. This launch marks a significant milestone in Pluss’ journey, reinforcing its dedication to delivering affordable, temperature-secure solutions to customers worldwide.

    Commenting on the launch, Samit Jain, managing director of Pluss, stated, “The Celsure® XL VIP pallets represent a significant leap forward in our commitment to delivering temperature-secure medicines affordably. It also strengthens India’s position as a world-class provider of quality packaging for pharmaceuticals.”

    The pallets address a variety of industry challenges. They ensure precise temperature control with PCM technology and VIP insulation, offering sustainability by being reusable, lower costs with a superior payload-to-volume ratio, and providing operational ease by seamlessly transitioning between air and road transport, ensuring uninterrupted supply chain operations. These locally manufactured solutions aligned with the ‘Atmanirbhar Bharat’ and ‘Make in India’ initiatives.

    Udit Mangal, vice president of life sciences and pharma at Pluss emphasized the company’s commitment to innovation and excellence. “Our relentless focus on research and development has enabled us to deliver world-class solutions tailored to the needs of the Indian market and help further India’s strength as a pharmacy of the world,” he said.

    The new product was recently unveiled in Chennai by M. M. Murugappan, chairman – CUMI and Sridharan Rangarajan, managing director – CUMI (Carborundum Universal), of the Murugappa Group.